Novartis signs new agreement with BioNTech for COVID-19 vaccine fill and finish

Novartis signs new agreement with BioNTech for COVID-19 vaccine fill and finish

Source: 
Biopharma Reporter
snippet: 

Novartis has signed a new initial agreement with BioNTech for COVID-19 vaccine manufacturing: with its sterile manufacturing facilities in Ljubljana, Slovenia, to fill at least 24 million doses in 2022.